{"pmid":32294238,"title":"Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.","text":["Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.","A novel coronavirus, currently identified as COVID-19, was recently defined as the cause of a cluster of patients with pneumonia of unknown origin that was initially reported from Wuhan, Hubei province, People's Republic of China.","Eur J Clin Invest","Bodini, Giorgia","Demarzo, Maria Giulia","Casagrande, Edoardo","De Maria, Costanza","Kayali, Stefano","Ziola, Sebastiano","Giannini, Edoardo G","32294238"],"abstract":["A novel coronavirus, currently identified as COVID-19, was recently defined as the cause of a cluster of patients with pneumonia of unknown origin that was initially reported from Wuhan, Hubei province, People's Republic of China."],"journal":"Eur J Clin Invest","authors":["Bodini, Giorgia","Demarzo, Maria Giulia","Casagrande, Edoardo","De Maria, Costanza","Kayali, Stefano","Ziola, Sebastiano","Giannini, Edoardo G"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294238","week":"202016|Apr 13 - Apr 19","doi":"10.1111/eci.13233","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295600742402,"score":8.233237,"similar":[{"pmid":32303607,"title":"British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.","text":["British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.","The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.","Gut","Kennedy, Nicholas A","Jones, Gareth-Rhys","Lamb, Christopher A","Appleby, Richard","Arnott, Ian","Beattie, R Mark","Bloom, Stuart","Brooks, Alenka J","Cooney, Rachel","Dart, Robin J","Edwards, Cathryn","Fraser, Aileen","Gaya, Daniel R","Ghosh, Subrata","Greveson, Kay","Hansen, Richard","Hart, Ailsa","Hawthorne, A Barney","Hayee, Bu'Hussain","Limdi, Jimmy K","Murray, Charles D","Parkes, Gareth C","Parkes, Miles","Patel, Kamal","Pollok, Richard C","Powell, Nick","Probert, Chris S","Raine, Tim","Sebastian, Shaji","Selinger, Christian","Smith, Philip J","Stansfield, Catherine","Younge, Lisa","Lindsay, James O","Irving, Peter M","Lees, Charlie W","32303607"],"abstract":["The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials."],"journal":"Gut","authors":["Kennedy, Nicholas A","Jones, Gareth-Rhys","Lamb, Christopher A","Appleby, Richard","Arnott, Ian","Beattie, R Mark","Bloom, Stuart","Brooks, Alenka J","Cooney, Rachel","Dart, Robin J","Edwards, Cathryn","Fraser, Aileen","Gaya, Daniel R","Ghosh, Subrata","Greveson, Kay","Hansen, Richard","Hart, Ailsa","Hawthorne, A Barney","Hayee, Bu'Hussain","Limdi, Jimmy K","Murray, Charles D","Parkes, Gareth C","Parkes, Miles","Patel, Kamal","Pollok, Richard C","Powell, Nick","Probert, Chris S","Raine, Tim","Sebastian, Shaji","Selinger, Christian","Smith, Philip J","Stansfield, Catherine","Younge, Lisa","Lindsay, James O","Irving, Peter M","Lees, Charlie W"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303607","week":"202016|Apr 13 - Apr 19","doi":"10.1136/gutjnl-2020-321244","keywords":["crohn's colitis","crohn's disease","ulcerative colitis"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"locations":["China","Italy","GBR","GBR","British"],"countries":["Italy","United Kingdom","China"],"countries_codes":["ITA|Italy","GBR|United Kingdom","CHN|China"],"_version_":1664431720487714818,"score":101.88871},{"pmid":32023684,"title":"[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].","text":["[Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].","At the end of 2019, sporadic and clustered case with \"pneumonia of unknown origin\" emerged in Wuhan, Hubei province. The causative pathogen was quickly confirmed as \"2019-nCoV\" . The epidemic soon spread throughout the country and became a pandemic in over a month. Government and medical institutions across the country mobilized all kinds of resources and took a variety of measures to actively treat patients and stop the epidemic. Based on current studies, the author summarized the clinical characteristics and evolution of the novel viral pneumonia, and proposed the key points of diagnosis and treatment, the scientific management of both confirmed and suspected cases, and the scientific management of disease prevention and control.","Zhonghua Jie He He Hu Xi Za Zhi","Gao, Z C","32023684"],"abstract":["At the end of 2019, sporadic and clustered case with \"pneumonia of unknown origin\" emerged in Wuhan, Hubei province. The causative pathogen was quickly confirmed as \"2019-nCoV\" . The epidemic soon spread throughout the country and became a pandemic in over a month. Government and medical institutions across the country mobilized all kinds of resources and took a variety of measures to actively treat patients and stop the epidemic. Based on current studies, the author summarized the clinical characteristics and evolution of the novel viral pneumonia, and proposed the key points of diagnosis and treatment, the scientific management of both confirmed and suspected cases, and the scientific management of disease prevention and control."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Gao, Z C"],"date":"2020-02-06T11:00:00Z","year":2020,"_id":"32023684","week":"20206|Feb 03 - Feb 09","doi":"10.3760/cma.j.issn.1001-0939.2020.0001","keywords":["Neumonia","Novel coronavirus"],"source":"PubMed","locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Treatment","Diagnosis"],"weight":1,"_version_":1663352134759874560,"score":92.44325},{"pmid":32234107,"title":"Epidemiological Features of 135 Patients with Coronavirus Disease (COVID-19) in Tianjin, China.","text":["Epidemiological Features of 135 Patients with Coronavirus Disease (COVID-19) in Tianjin, China.","OBJECTIVE: To describe the epidemiologic features of an outbreak of coronavirus disease (COVID-19) in Tianjin caused by a novel coronavirus (2019-nCoV) and to provide scientific basis for prevention and control measures. METHODS: Data from COVID-19 cases were collected from daily notifications given to the National Health Commission of the People's Republic of China and Tianjin Health Committee. All of the data were analyzed with SPSS version 24.0 software. RESULTS: As of February 24, 2020, there have been 135 confirmed cases, 3 deaths, and 87 recoveries in Tianjin, China. The incidence of COVID-19 was 8.65/1,000,000 with a 2.22% case fatality rate. Regarding geographic distribution, the incidence was 8.82 per 1,000,000 in urban areas and 8.00 per 1,000,000 in suburbs. During the early stage of the epidemic, most cases came from urban areas and in patients with a history of sojourning in Hubei Province. The majority of patients were 31-70 years old (75.97%). A familial cluster was the most important characteristic of COVID-19 (accounting for 74.81%). CONCLUSIONS: Current information suggests that people are generally susceptible to COVID-19, which has shown a familial cluster in Tianjin.","Disaster Med Public Health Prep","Cao, Chunxia","Li, Yue","Liu, Shuyu","Fan, Haojun","Hao, Liangchen","32234107"],"abstract":["OBJECTIVE: To describe the epidemiologic features of an outbreak of coronavirus disease (COVID-19) in Tianjin caused by a novel coronavirus (2019-nCoV) and to provide scientific basis for prevention and control measures. METHODS: Data from COVID-19 cases were collected from daily notifications given to the National Health Commission of the People's Republic of China and Tianjin Health Committee. All of the data were analyzed with SPSS version 24.0 software. RESULTS: As of February 24, 2020, there have been 135 confirmed cases, 3 deaths, and 87 recoveries in Tianjin, China. The incidence of COVID-19 was 8.65/1,000,000 with a 2.22% case fatality rate. Regarding geographic distribution, the incidence was 8.82 per 1,000,000 in urban areas and 8.00 per 1,000,000 in suburbs. During the early stage of the epidemic, most cases came from urban areas and in patients with a history of sojourning in Hubei Province. The majority of patients were 31-70 years old (75.97%). A familial cluster was the most important characteristic of COVID-19 (accounting for 74.81%). CONCLUSIONS: Current information suggests that people are generally susceptible to COVID-19, which has shown a familial cluster in Tianjin."],"journal":"Disaster Med Public Health Prep","authors":["Cao, Chunxia","Li, Yue","Liu, Shuyu","Fan, Haojun","Hao, Liangchen"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234107","week":"202014|Mar 30 - Apr 05","doi":"10.1017/dmp.2020.63","keywords":["2019-nCoV","Coronavirus disease","Epidemiology"],"source":"PubMed","locations":["Tianjin","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1663352135450886144,"score":86.772316},{"pmid":32246874,"title":"Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.","text":["Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.","J Gastroenterol Hepatol","Pasha, Syed Bilal","Fatima, Huda","Ghouri, Yezaz A","32246874"],"journal":"J Gastroenterol Hepatol","authors":["Pasha, Syed Bilal","Fatima, Huda","Ghouri, Yezaz A"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246874","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jgh.15056","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1663352135864025088,"score":85.53542},{"pmid":32235085,"title":"The novel zoonotic COVID-19 pandemic: An expected global health concern.","text":["The novel zoonotic COVID-19 pandemic: An expected global health concern.","18 years ago, in 2002, the world was astonished by the appearance of Severe Acute Respiratory Syndrome (SARS), supported by a zoonotic coronavirus, called SARS-CoV, from the Guangdong Province of southern China. After about 10 years, in 2012, another similar coronavirus triggered the Middle East Respiratory Syndrome (MERS-CoV) in Saudi Arabia. Both caused severe pneumonia killing 774 and 858 people with 8700 cases of confirmed infection for the former, and 2494 for the latter, causing significant economic losses. 8 years later, despite the MERS outbreak remaining in certain parts of the world, at the end of 2019, a new zoonotic coronavirus (SARS-CoV-2) and responsible of coronavirus Disease (COVID-19), arose from Wuhan, Hubei Province, China. It spread rapidly and to date has killed 3,242 persons with more than 81,000 cases of infection in China and causing over 126,000 global cases and 5,414 deaths in 166 other countries around the world, especially Italy. SARS-CoV-2 would seem to have come from a bat, but the intermediate reservoir continues to be unknown. Nonetheless, as for SARS-CoV and MERS CoV, the Spillover effect linked to animal-human promiscuity, human activities including deforestation, illegal bush-trafficking and bushmeat, cannot be excluded. Recently, however, evidence of inter-human only transmission of SARS-CoV-2 has been accumulated and thus, the outbreak seems to be spreading by human-to-human transmission throughout a large part of the world. Herein we will provide with an update on the main features of COVID-19 and suggest possible solutions how to halt the expansion of this novel pandemic.","J Infect Dev Ctries","Contini, Carlo","Di Nuzzo, Mariachiara","Barp, Nicole","Bonazza, Aurora","De Giorgio, Roberto","Tognon, Mauro","Rubino, Salvatore","32235085"],"abstract":["18 years ago, in 2002, the world was astonished by the appearance of Severe Acute Respiratory Syndrome (SARS), supported by a zoonotic coronavirus, called SARS-CoV, from the Guangdong Province of southern China. After about 10 years, in 2012, another similar coronavirus triggered the Middle East Respiratory Syndrome (MERS-CoV) in Saudi Arabia. Both caused severe pneumonia killing 774 and 858 people with 8700 cases of confirmed infection for the former, and 2494 for the latter, causing significant economic losses. 8 years later, despite the MERS outbreak remaining in certain parts of the world, at the end of 2019, a new zoonotic coronavirus (SARS-CoV-2) and responsible of coronavirus Disease (COVID-19), arose from Wuhan, Hubei Province, China. It spread rapidly and to date has killed 3,242 persons with more than 81,000 cases of infection in China and causing over 126,000 global cases and 5,414 deaths in 166 other countries around the world, especially Italy. SARS-CoV-2 would seem to have come from a bat, but the intermediate reservoir continues to be unknown. Nonetheless, as for SARS-CoV and MERS CoV, the Spillover effect linked to animal-human promiscuity, human activities including deforestation, illegal bush-trafficking and bushmeat, cannot be excluded. Recently, however, evidence of inter-human only transmission of SARS-CoV-2 has been accumulated and thus, the outbreak seems to be spreading by human-to-human transmission throughout a large part of the world. Herein we will provide with an update on the main features of COVID-19 and suggest possible solutions how to halt the expansion of this novel pandemic."],"journal":"J Infect Dev Ctries","authors":["Contini, Carlo","Di Nuzzo, Mariachiara","Barp, Nicole","Bonazza, Aurora","De Giorgio, Roberto","Tognon, Mauro","Rubino, Salvatore"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235085","week":"202014|Mar 30 - Apr 05","doi":"10.3855/jidc.12671","keywords":["*COVID-19","*MERS CoV","*SARS CoV","*SARS-CoV-2","*drugs","*spillover"],"source":"PubMed","locations":["Wuhan","China","Hubei","Saudi Arabia","Italy"],"countries":["Saudi Arabia","China","Italy"],"countries_codes":["SAU|Saudi Arabia","CHN|China","ITA|Italy"],"topics":["Transmission"],"weight":1,"_version_":1663352135459274752,"score":84.82701}]}